Skip to main content

Publication, Part of

Health and Care of People with Learning Disabilities Experimental Statistics 2019 to 2020

Experimental statistics, Other reports and statistics

Current Chapter

Health and Care of People with Learning Disabilities Experimental Statistics 2019 to 2020


Summary

The outbreak of Coronavirus (COVID-19) has led to unprecedented changes in the work and behaviour of GP practices and consequently the data in this publication may have been impacted, including indicators and contextual data from patients registered at a GP Practice.

The data is extracted through the General Practice Extraction Service (GPES) therefore the burden of the Coronavirus (COVID-19) outbreak has not affected the collection of data for this publication.

Caution should be taken in drawing any conclusions from this data without due consideration of the circumstances both locally and nationally as of 1 January 2020 and NHS Digital would recommend that any use of this data is accompanied by an appropriate caveat.

This publication supersedes and is not comparable with previous versions due to changes to the code clusters used to identify patients with a learning disability. In addition, new indicators have been introduced:

• Two indicators for patients who had a learning disability health check under the Enhanced Service with new age bands which align with Quality and Outcomes Framework (QOF) data.

• Fourteen indicators to monitor the prescription of medication to patients with a learning disability to support the NHS STOMP (stopping over medication of people with a learning disability, autism, or both) campaign.

• Nine redundant indicators have also been retired. More information on these changes can be found in the Data Quality section of this publication.

The aim of this publication is to provide information about the key differences in healthcare between people with a learning disability and those without. It contains aggregated data on key health issues for people who are recorded by their GP as having a learning disability, and comparative data about a control group who are recorded by their GP as not having a learning disability.

Data has been collected from participating practices using EMIS, EVA Health Technologies formerly MICROTEST and Cegedim Healthcare Systems formerly VISION GP practice systems.

This publication does not include sections on 'Life Expectancy' and 'Mortality' due to issues in obtaining mortality data. Analysis on the excess mortality indicator and life expectancy comparisons will be published at a future date when the data becomes available.


Key Facts

England, 2019-20

Coverage

56.6% of patients registered in England in 2019-20 were included in this publication.

Learning Disability Prevalence

0.5% of the patients included in this publication were recorded by their GP as having a learning disability in 2019-20.

Health Checks

57.8% of patients with a learning disability had a Learning Disability Health Check in 2019-20, a statistically significant increase from 51.6% in 2015-16.

ADHD, Autism and Epilepsy

In 2019-20 the percentage of patients with a learning disability who had a diagnosis of ADHD was significantly higher (6.5%) than in patients without a learning disability (0.6%). the percentage of patients with a learning disability who had a diagnosis of autism was significantly higher (24.8%) than in patients without a learning disability (0.7%). the percentage of patients with a learning disability who had a diagnosis of epilepsy and are currently on a drug treatment for epilepsy was significantly higher (16.7%) than in patients without a learning disability (0.6%).  

Cancer screening

33.6% of eligible patients with a learning disability had an adequate smear test in 2019-20, an increase of 2.4 percentage points from 2015-16 (31.2%). The percentage of eligible patients without a learning disability who had an adequate smear test increased by 0.7 percentage points over the same period (71.0% 2015-16 to 71.8% 2019-20).

Prescribing

In 2019-20 the percentage of patients with a learning disability who had been prescribed antipsychotics was significantly higher (15.2%) than in patients without a learning disability (0.9%). the percentage of patients with a learning disability who had who had been prescribed benzodiazepines was significantly higher (7.2%) than in patients without a learning disability (2.1%). the percentage of patients with a learning disability who been treated with antidepressants without an active diagnosis of depression was significantly higher (11.6%) than in patients without a learning disability (4.4%). the percentage of patients with a learning disability who been treated with epilepsy drugs without an active diagnosis of epilepsy was significantly higher (5.6%) than in patients without a learning disability (2.4%).





Last edited: 25 May 2021 8:50 am